Positron has positioned itself as a recognized pioneer within the field of nuclear cardiology. Positron’s business strategy has evolved from simply being an imaging system provider, to a “full solutions” provider within the nuclear cardiology imaging community. Positron is actively pursuing key initiatives to ensure the growth and longevity of the company, as well as, the industry by securing the supply of key isotopes, providing necessary radiopharmaceuticals that apply to both PET and SPECT imaging modalities and offering attractive financing solutions.
Positron Corporation is a publicly listed company and files annual, quarterly, special reports, proxy statements and other information with the SEC. Shares of common stock are currently trading on the National Association of Securities Dealers, Inc.’s OTC Bulletin Board under the symbol POSC.OB.
Investor Contact
To improve communications with our investors we encourage you to contact us directly.
317.576.0183
investor@positron.com
